Palo Alto, CA, United States of America

Robert T Jacobs

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mmv Medicines for Malaria Venture. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert T Jacobs. Retrieved from https://idiyas.com/inventor/robert-t-jacobs-uh6vb6m4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Robert T Jacobs in Antiprotozoal Agents

Introduction

Robert T Jacobs is an accomplished inventor based in Palo Alto, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for treating protozoal infections. His work is crucial in addressing health challenges posed by these infections.

Latest Patents

Robert T Jacobs holds a patent for "Boron-containing small molecules as antiprotozoal agents." This invention provides innovative compounds that are useful for treating protozoal infections. The patent also includes pharmaceutical compositions containing these compounds, as well as combinations with at least one additional therapeutically effective agent.

Career Highlights

Jacobs is associated with Medicines for Malaria Venture, a company dedicated to developing new treatments for malaria. His work in this organization highlights his commitment to improving global health through innovative solutions.

Collaborations

He has collaborated with notable colleagues such as Yong-Kang Zhang and Jacob J Plattner, contributing to the advancement of research in his field.

Conclusion

Robert T Jacobs exemplifies the spirit of innovation in the pharmaceutical industry, particularly in the fight against protozoal infections. His contributions are vital for developing effective treatments that can save lives.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…